[1] Freaney PM, Khan SS, Lloyd-Jones DM, et al. The role of sex-specific risk factors in the risk assessment of atherosclerotic cardiovascular disease for primary prevention in women[J]. Curr Atheroscler Rep, 2020, 22(9): 46. [2] Zhu D, Chung HF, Dobson AJ, et al. Type of menopause, age of menopause and variations in the risk of incident cardiovascular disease: pooled analysis of individual data from 10 international studies[J]. Hum Reprod, 2020, 35(8): 1933-1943. [3] Kumar A, Boovarahan SR, Prem PN, et al. Evaluating the effects of carbon monoxide releasing molecule-2 against myocardial ischemia-reperfusion injury in ovariectomized female rats[J]. Naunyn Schmiedebergs Arch Pharmacol, 2021, 394(10): 2103-2115. [4] 钱 鲁, 李卓远, 张素勤. 雌二醇对小鼠急性心肌缺血再灌注损伤的保护作用及其机制[J]. 温州医科大学学报, 2021, 51(7): 548-553. [5] 张梦颖, 杨玉有, 刘 敏, 等. 雌二醇通过 ERβ调控 ERK 磷酸化影响细胞增殖和凋亡[J]. 南方医科大学学报, 2021, 41(3): 336-343. [6] 骆燕萍, 俞艳烨, 邹 茜. 绝经前后冠心病患者临床特点雌激素及冠状动脉病变特征分析[J]. 中国妇幼保健, 2021, 36(20): 4846-4848. [7] Wang A, Gerstein HC, Lee SF, et al. Testosterone and sex hormone-binding globulin in dysglycemic women at high cardiovascular risk: A report from the outcome reduction with an initial glargine intervention trial[J]. Diab Vasc Dis Res, 2021, 18(2): 14791641211002475. [8] Yang Y, Wang IW, Turrentine M, et al. Postischemic application of estrogen ameliorates myocardial damage in an in vivo mouse model[J]. J Surg Res, 2018, 231: 366-372. [9] Wang M, Smith K, Yu Q, et al. Mitochondrial connexin 43 in sex-dependent myocardial responses and estrogen-mediated cardiac protection following acute ischemia/reperfusion injury[J]. Basic Res Cardiol, 2019, 115(1): 1. [10] da Silva JS, Montagnoli TL, Rocha BS, et al. Estrogen receptors: Therapeutic perspectives for the treatment of cardiac dysfunction after myocardial infarction[J]. Int J Mol Sci, 2021, 22(2): 525. [11] Zhai P, Eurell TE, Cooke PS, et al. Myocardial ischemia-reperfusion injury in estrogen receptor-alpha knockout and wild-type mice[J]. Am J Physiol Heart Circ Physiol, 2000, 278(5): H1640-7. [12] Bozdogan O, Bozcaarmutlu A, Kaya ST, et al. Decreasing myocardial estrogen receptors and antioxidant activity may be responsible for increasing ischemia- and reperfusion-induced ventricular arrhythmia in older female rats[J]. Life Sci, 2021, 15(271): 119190. [13] Dworatzek E, Mahmoodzadeh S, Dworatzek E, et al. Targeted basic research to highlight the role of estrogen and estrogen receptors in the cardiovascular system[J]. Pharmacol Res, 2017, 119: 27-35. [14] Quast A, Martian V, Bohnsack A, et al. Donor variation and sex hormone receptors in periodontal ligament cells[J]. Transplant Proceed, 2020, 122(105): 1026-1037. [15] Xie D, Zhao J, Guo R, et al. Sevoflurane pre-conditioning ameliorates diabetic myocardial ischemia/reperfusion injury via differential regulation of p38 and ERK[J]. Sci Rep, 2020, 10(1): 23. [16] Li W, Li Y, Chu Y, et al. PLCE1 promotes myocardial ischemia-reperfusion injury in H/R H9c2 cells and I/R rats by promoting inflammation[J]. Biosci Rep, 2019, 39(7): BSR20181613. [17] Wang L, Niu H, Zhang J, et al. Homocysteine induces mitochondrial dysfunction and oxidative stress in myocardial ischemia/reperfusion injury through stimulating ROS production and the ERK1/2 signaling pathway[J]. Exp Ther Med, 2020, 20(2): 938-944. |